United Therapeutics reported $6.04B in Assets for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Amarin AMRN:US USD 908.3M 64.93M
Ardelyx ARDX:US USD 190.07M 45.39M
Baxter International BAX:US USD 28.29B 322M
Bayer BAYN:GR EUR 124.88B 6.13B
Biocryst Pharmaceuticals BCRX:US USD 550M 8.59M
Biogen BIIB:US USD 24.55B 300.1M
Biomarin Pharmaceutical BMRN:US USD 6.38B 111.03M
Emergent Biosolutions EBS:US USD 3.17B 258.1M
Esperion Therapeutics ESPR:US USD 247.94M 64.89M
Gilead Sciences GILD:US USD 63.17B 614M
GlaxoSmithKline GSK:LN GBP 60.15B 167M
Halozyme Therapeutics HALO:US USD 1.84B 23.03M
Insmed INSM:US USD 1.66B 661.62M
Intercept Pharmaceuticals ICPT:US USD 553.71M 5.69M
Intra Cellular Therapies ITCI:US USD 754.78M 27.22M
Lexicon Pharmaceuticals LXRX:US USD 194.3M 2.61M
Moderna Inc MRNA:US USD 25.86B 198M
Omeros OMER:US USD 590.97M 133.42M
Ptc Therapeutics PTCT:US USD 1.71B 129.22M
Regeneron Pharmaceuticals REGN:US USD 29.21B 1.54B
Sangamo Biosciences SGMO:US USD 562.51M 31.4M
Sarepta Therapeutics SRPT:US USD 3.13B 27.78M
Seattle Genetics SGEN:US USD 3.67B 55.45M
Teva Pharmaceutical TEVA:IT USD 44.01B 246M
United Therapeutics UTHR:US USD 6.04B 262.9M
Vertex Pharmaceuticals VRTX:US USD 18.15B 1.44B